FindTrial
Sign In

?Pharmaceutical Service Model Construction and Evaluation for Elderly Coronary Heart Disease Patients' Participation in Medication Safety Management

Pharmaceutical Service Model Construction and Evaluation for Elderly Coronary Heart Disease Patients' Participation in Medication Safety Management - ?Pharmaceutical Service Model for Elderly Coronary Heart Disease Patients' Participation in Medication Safety Management

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094344
Enrollment
Unknown
Registered
2024-12-20
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Intervention group:Doctor service + Pharmaceutical care
Control group:Doctor servic

Sponsors

Aerospace Center Hospital?
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: ?Part1 Baseline Survey ?Inclusion Criteria?: ?Age?: =60 years old. ?Diagnosis?: Meets the 2018 diagnostic criteria for stable coronary heart disease. ? ? Part 3 Implementation and Effect Evaluation of PS-PE-MSM Model ?Inclusion Criteria?: ?Family Doctor?: Patients who have signed up with a family doctor. ?Diagnosis?: Meets the 2018 diagnostic criteria for stable coronary heart disease. ?Age?: =60 years old. ?Adherence?: MARS-5 score <23. ?Literacy?: Basic reading, understanding, and writing abilities to complete questionnaires. ?Consent?: Voluntary participation and signed informed consent. ?

Exclusion criteria

Exclusion criteria: Part 1 Baseline Survey ?Exclusion Criteria?: ?Intellectual Impairment?: Mini-cog score <3. ?Non-consent?: Refusal to sign the informed consent form. P?art 3 Implementation and Effect Evaluation of PS-PE-MSM Model ?Exclusion Criteria?: ?Impairments?: Mini-cog score <3 or ADL score <40. ?Malignancy?: Diagnosed with malignant tumors. ?

Design outcomes

Primary

MeasureTime frame
Medication compliance;—

Secondary

MeasureTime frame
medication literacy;Potentially Inappropriate Medications (PIM);Drug-related Problems (DRP);Patient Activism Measure (PAM);Low-density lipoprotein (LDL-C);readmission rate;—

Countries

China

Contacts

Public ContactLiu Hua

Aerospace Center Hospital?

lcyx721@126.com+86 138 1098 5170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026